Doxorubicin–trabectedin with trabectedin maintenance in leiomyosarcoma

P Pautier, A Italiano, S Piperno-Neumann… - … England Journal of …, 2024 - Mass Medical Soc
Background The addition of trabectedin to doxorubicin, followed by trabectedin
maintenance, may have superior efficacy to doxorubicin alone as first-line treatment in …

Sarcoma care in the era of precision medicine

K Wallander, I Öfverholm, K Boye… - Journal of Internal …, 2023 - Wiley Online Library
Sarcoma subtype classification is currently mainly based upon histopathological
morphology. Molecular analyses have emerged as an efficient addition to the diagnostic …

Atezolizumab as the first systemic therapy approved for alveolar soft part sarcoma

EJ Bergsma, M Elgawly, D Mancuso… - Annals of …, 2024 - journals.sagepub.com
Objective The objective was to review the pharmacology, efficacy, and safety of
atezolizumab (Tecentriq) for the treatment of adult and pediatric patients aged 2 years and …

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years

JY Blay, S Piperno-Neumann, S Watson… - European Journal of …, 2023 - Elsevier
Epithelioid hemangioendothelioma: a nationwide study Epithelioid hemangioendothelioma
(EHE) is an ultrarare sarcoma whose natural history and treatment is not well defined. We …

Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin …

S Watanabe, T Shimoi, T Nishikawa, A Kawachi… - Scientific Reports, 2023 - nature.com
Prognostic value of hematologic indices and their association with the tumor
microenvironment (TME) remain unclear in advanced soft tissue sarcoma (STS). We aimed …

Systematic Review of the Gonadotoxicity and Risk of Infertility of Soft Tissue Sarcoma Chemotherapies in Pre-and Postpubertal Females and Males

M Steinmann, A Rietschin, F Pagano… - Journal of Adolescent …, 2024 - liebertpub.com
Increasing awareness of gonadotoxicity in cancer treatments and infertility risk is essential
for counseling young cancer patients. While fertility preservation options are available in …

Safety and efficacy of percutaneous cryoablation for recurrent or metastatic soft-tissue sarcoma in adult patients

K Pal, A Awad, S Yevich, JD Kuban, AL Tam… - American Journal of …, 2024 - ajronline.org
BACKGROUND. Treatment options are limited in patients with recurrent or metastatic
disease after initial treatment of soft-tissue sarcoma (STS) by surgical resection, radiation, or …

Myxoid liposarcomas: systemic treatment options

EF Nassif, EZ Keung, P Thirasastr… - Current treatment options …, 2023 - Springer
Opinion Statement Myxoid/round-cell liposarcoma (MRCL) account for 30% of liposarcomas
and are the most chemo-sensitive subtype of liposarcoma. The 5-year local relapse and …

[HTML][HTML] The landscape of drug sensitivity and resistance in sarcoma

A Al Shihabi, PJ Tebon, HTL Nguyen… - Cell stem cell, 2024 - cell.com
Sarcomas are rare malignancies with over 100 distinct histological subtypes. Their rarity and
heterogeneity pose significant challenges to identifying effective therapies, and approved …

Immune cells in the tumor microenvironment of soft tissue sarcomas

E Jumaniyazova, A Lokhonina, D Dzhalilova… - Cancers, 2023 - mdpi.com
Simple Summary Soft tissue sarcomas represent a large heterogeneous group of malignant
neoplasms that are characterized by a poor disease outcome and being poorly studied …